Halozyme Therapeutics
HALO
#2108
Rank
โ‚น862.72 B
Marketcap
โ‚น7,336
Share price
3.58%
Change (1 day)
44.56%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: โ‚น862.72 Billion

As of February 2026 Halozyme Therapeutics has a market cap of โ‚น862.72 Billion. This makes Halozyme Therapeutics the world's 2108th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น862.72 B18.66%
2025โ‚น727.03 B38.4%
2024โ‚น525.30 B29.24%
2023โ‚น406.44 B-36.16%
2022โ‚น636.64 B51.09%
2021โ‚น421.35 B-0.21%
2020โ‚น422.25 B144.28%
2019โ‚น172.85 B16.75%
2018โ‚น148.04 B-19.61%
2017โ‚น184.15 B111.82%
2016โ‚น86.93 B-41.09%
2015โ‚น147.58 B91.95%
2014โ‚น76.89 B-27.51%
2013โ‚น106.06 B156.15%
2012โ‚น41.40 B-20.62%
2011โ‚น52.16 B46.14%
2010โ‚น35.69 B42.95%
2009โ‚น24.97 B13.91%
2008โ‚น21.92 B0.85%
2007โ‚น21.73 B-11.3%
2006โ‚น24.50 B396.68%
2005โ‚น4.93 B5.26%
2004โ‚น4.68 B

End of Day market cap according to different sources

On Feb 6th, 2026 the market cap of Halozyme Therapeutics was reported to be:

โ‚น862.72 Billion
by Nasdaq info icon info icon
โ‚น862.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น52.220 T 5,953.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.977 T 1,520.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น85.673 T 9,830.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.492 T 1,116.17%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
โ‚น1.008 T 16.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚น160.29 B-81.42%๐Ÿ‡บ๐Ÿ‡ธ USA